RO6870810 is a new drug being investigated as a treatment for myeloma and other cancers. It belongs to a class of drugs called Bromodomain and Extra-Terminal Protein (BET) Inhibitors.
| SparkCures ID | 277 |
|---|---|
| Developed By | Hoffmann-La Roche |
| Generic Name | RO6870810 |
| Treatment Classifications |
There are no resources, links or videos to display for this treatment.
SparkCures is working closely with Hoffmann-La Roche to provide the most up-to-date information on this treatment. Use the button above to add this treatment to your list of favorites.
Learn more about how we work with industry partners